Opinion:
Quite the sales pitch once again. Once again, there have been interested parties and there still are… Of course, the share price needs to be revived somehow, but still. 80% of my position is gone, and I’m not really sure about subscribing while staying on board with this gentleman.
How is this CEO guy still allowed to continue in this role?
I’m already tired of listening to him, and I’m sure it’s the same out there in the world; surely no executive or negotiator from big or mid-sized pharma gets a very honest impression of him?